Utah Medical Products (UTMD) EBIT Margin (2016 - 2025)
Historic EBIT Margin for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to 26.61%.
- Utah Medical Products' EBIT Margin fell 68000.0% to 26.61% in Q3 2025 from the same period last year, while for Sep 2025 it was 30.78%, marking a year-over-year decrease of 23600.0%. This contributed to the annual value of 6.83% for FY2024, which is 21600.0% up from last year.
- Per Utah Medical Products' latest filing, its EBIT Margin stood at 26.61% for Q3 2025, which was down 68000.0% from 32.11% recorded in Q2 2025.
- In the past 5 years, Utah Medical Products' EBIT Margin ranged from a high of 40.55% in Q3 2021 and a low of 26.61% during Q3 2025
- In the last 5 years, Utah Medical Products' EBIT Margin had a median value of 34.39% in 2023 and averaged 34.86%.
- Per our database at Business Quant, Utah Medical Products' EBIT Margin skyrocketed by 153100bps in 2021 and then plummeted by -79400bps in 2023.
- Utah Medical Products' EBIT Margin (Quarter) stood at 39.72% in 2021, then dropped by -6bps to 37.35% in 2022, then dropped by -14bps to 31.98% in 2023, then increased by 0bps to 32.0% in 2024, then decreased by -17bps to 26.61% in 2025.
- Its EBIT Margin stands at 26.61% for Q3 2025, versus 32.11% for Q2 2025 and 32.47% for Q1 2025.